the FDA very specifically said that they did not think that providing samples to generic manufacturers would create a safety concern.
Prevention of generic encroachment just means to delay generic competition.
It is unacceptable.
Congress has created--has acted to address inappropriate usage of safety programs through the CREATES Act last year.
This program is supposed to be used to protect patient safety.
As a breast cancer survivor, the high cost of cancer treatment is very personal to me.
Encouraging generic competition is crucial to ensuring that brand-name drugs become more affordable, but some drug compa...
The threat of White supremacy has become really more dangerous than ever, and meanwhile, the presence of White supremaci...
These examples, alone, are too many, and they undermine our Nation's promise of equal justice.
I'm concerned about the--what I've seen as a reduction in the prioritization of the continued rights and progress of Afg...
Is it a priority of the administration to include in the negotiations and the ongoing assistance that we provide to the ...